98 related articles for article (PubMed ID: 20036120)
1. Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.
Schnatbaum K; Schaudt M; Stragies R; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Zischinsky G
Bioorg Med Chem Lett; 2010 Feb; 20(3):1233-6. PubMed ID: 20036120
[TBL] [Abstract][Full Text] [Related]
2. Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides.
Schaudt M; Locardi E; Zischinsky G; Stragies R; Pfeifer JR; Gibson C; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1225-8. PubMed ID: 20015645
[TBL] [Abstract][Full Text] [Related]
3. Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.
Zischinsky G; Stragies R; Schaudt M; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1229-32. PubMed ID: 20015651
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
[TBL] [Abstract][Full Text] [Related]
5. Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.
Wood MR; Schirripa KM; Kim JJ; Kuduk SD; Chang RK; Di Marco CN; DiPardo RM; Wan BL; Murphy KL; Ransom RW; Chang RS; Holahan MA; Cook JJ; Lemaire W; Mosser SD; Bednar RA; Tang C; Prueksaritanont T; Wallace AA; Mei Q; Yu J; Bohn DL; Clayton FC; Adarayn ED; Sitko GR; Leonard YM; Freidinger RM; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2008 Jan; 18(2):716-20. PubMed ID: 18061443
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
[TBL] [Abstract][Full Text] [Related]
7. Indazole derivatives as novel bradykinin B1 receptor antagonists.
Bodmer-Narkevitch V; Anthony NJ; Cofre V; Jolly SM; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG; Kuduk SD
Bioorg Med Chem Lett; 2010 Dec; 20(23):7011-4. PubMed ID: 20971001
[TBL] [Abstract][Full Text] [Related]
8. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
[TBL] [Abstract][Full Text] [Related]
9. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
[TBL] [Abstract][Full Text] [Related]
10. Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core.
Ritchie TJ; Dziadulewicz EK; Culshaw AJ; Müller W; Burgess GM; Bloomfield GC; Drake GS; Dunstan AR; Beattie D; Hughes GA; Ganju P; McIntyre P; Bevan SJ; Davis C; Yaqoob M
J Med Chem; 2004 Sep; 47(19):4642-4. PubMed ID: 15341478
[TBL] [Abstract][Full Text] [Related]
11. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.
Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL
J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198
[TBL] [Abstract][Full Text] [Related]
12. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
[TBL] [Abstract][Full Text] [Related]
13. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.
Kuduk SD; Chang RK; Ng C; Murphy KL; Ransom RW; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2005 Sep; 15(17):3925-9. PubMed ID: 15993596
[TBL] [Abstract][Full Text] [Related]
16. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
Morissette G; Bouthillier J; Marceau F
Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
[TBL] [Abstract][Full Text] [Related]
17. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
[TBL] [Abstract][Full Text] [Related]
18. Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.
Dressen D; Garofalo AW; Hawkinson J; Hom D; Jagodzinski J; Marugg JL; Neitzel ML; Pleiss MA; Szoke B; Tung JS; Wone DW; Wu J; Zhang H
J Med Chem; 2007 Oct; 50(21):5161-7. PubMed ID: 17880055
[TBL] [Abstract][Full Text] [Related]
19. Kinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisation.
Kuebler JF; Schremmer-Danninger E; Bhoola KD; Roscher AA; Messmer K; Hoffmann TF
Biol Chem; 2003 Sep; 384(9):1311-9. PubMed ID: 14515994
[TBL] [Abstract][Full Text] [Related]
20. Novel small molecule bradykinin B2 receptor antagonists.
Gibson C; Schnatbaum K; Pfeifer JR; Locardi E; Paschke M; Reimer U; Richter U; Scharn D; Faussner A; Tradler T
J Med Chem; 2009 Jul; 52(14):4370-9. PubMed ID: 19552431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
